The largest database of trusted experimental protocols

In fusion enzyme

Manufactured by Takara Bio
Sourced in Japan, United States, China

The In-Fusion enzyme is a high-performance cloning kit designed for fast and efficient DNA assembly. The enzyme facilitates the seamless joining of DNA fragments, enabling the creation of custom DNA constructs with precision. This product offers a reliable and streamlined cloning solution for a variety of molecular biology applications.

Automatically generated - may contain errors

24 protocols using in fusion enzyme

1

Bik-1 mRNA Rescue Experiment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bik-1 mRNA containing its 5’UTR and open reading frame (but lacking the Bik-1 LNA target site) was amplified from cDNAs via PCR and cloned into pT3TS-nCas9n vector (addgene #46757, a gift from Ariel Bazzini). Bik-1 mRNA was then synthesized using mMESSAGE mMACHINE T3 Transcription Kit (AM1348). The mRNA was purified using RNeasy kit from Qiagen. The Bik-1 mRNA (153 pg) combined with Bik-1 LNA (22 pg) or Bik-1 LNA alone were co-injected into embryos at one-cell stage as the rescue experiment. Injected embryos then collected at 12 hpf for in situ hybridization.
We used In-Fusion enzyme (Takara Bio, #638947) to create a single nucleotide substitution on the 69th amino acid (Leucine to Stop) of Gag. The Bik-1 mRNA with the mutation (Rescue-Stop) was synthesized and purified as above. The Bik-1 mRNA with the mutation (153 pg) combined with Bik-1 LNA (22 pg) or Bik-1 LNA alone were co-injected into embryos at one-cell stage as in the original rescue experiment. Injected embryos were then collected at 12 hpf for in situ hybridization.
+ Open protocol
+ Expand
2

Overexpression of PsnNAC090 in Tobacco

Check if the same lab product or an alternative is used in the 5 most similar protocols
An overexpression vector containing PsnNAC090 was constructed using a homologous fusion method. The homologous arm containing a Spe1 digestion site was introduced at both ends of PsnNAC090 and reconstituted with a pBI121 vector using infusion enzyme (bought from Takara). The recombinant vectors were transferred into GV3101 Agrobacterium tumefaciens. Positive strains were cultured with OD600 of 0.6 in LB liquid medium containing 50 mg/L rifampicin and 50 mg/L kanamycin. The leaves of three-week-old tobacco plants were cut to 1.0 × 1.0 cm and soaked in the bacterial solution for 10 min. Then, the leaf pieces were cultured in screening medium containing 50 mg/L kanamycin and 200 mg/L ceftriaxone sodium until resistant young shoots sprouted. Then, the resistant seedlings were obtained by culturing resistant shoots in MS medium containing 50 mg/L kanamycin and 200 mg/L ceftriaxone sodium. DNA was extracted from the leaves of resistant seedlings for molecular identification using specific primers of pBI121-GFP vectors (Supplementary Table S2 and Figure S1). Three molecularly positive tobacco lines were randomly selected to collect their T1 seeds. Then, the T1 seeds were sterilized and screened in MS medium containing 100 mg/L kanamycin and 200 mg/L ceftriaxone sodium, and T2 and T3 seeds were obtained in the same way.
+ Open protocol
+ Expand
3

Generating Transgenic Arabidopsis Lines with ATM

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate 35S:GFP-ATM/Col-0, the full-length ATM CDS sequence was amplified and then inserted into pEGAD vector [33 (link)]. To construct ProATM:GUS/Col-0, a 3 kb genomic promoter sequence was amplified and inserted into pBI101 vector [34 (link)]. The amplified fragments were inserted into respective vectors by using the in-fusion enzyme (TAKARA, Shiga, Japan). All constructs were transformed into Agrobacterium tumefaciens cells (strain GV3101) which was used to transform Col-0 plants by the floral dip method [35 (link)]. All primer sequences used here are listed in Supplementary Table S1.
+ Open protocol
+ Expand
4

Mouse MARCKS Lentiviral Cloning

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse MARCKS was amplified by PCR using primer containing 15 bp overlap complementary to the vector ends at the 5’ end of the forward and reverse primers (5’-AGATCTGCCGCCGCGATCGCATGGGTGCCCAGTTCTCC-3’) and (5’-GCGGCCGCGTACGCGTTTACTCGGCCGTTGGCGC-3’). The PCR products were cloned into third-generation lentiviral vector, pLenti-C-mGFP (OriGene, Rockville, MD, USA) using infusion enzyme (TAKARA, Kusatsu, Japan). Plasmid sequences were verified by Sanger sequencing at Psomagen Inc (Rockville, MD, USA).
+ Open protocol
+ Expand
5

Purification of Recombinant MMP9 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
KOD-plus Neo kit was obtained from Toyobo (Osaka, Japan). Infusion enzyme was obtained from TaKaRa (Tokyo, Japan). E. coli SHuffle T7 Express lysY were obtained from New England Biolabs Korea (Seoul, Korea). A plasmid miniprep kit and oligonucleotides were obtained from Bionics (Daejeon, Korea). His Sepharose Ni was obtained from GE healthcare (Piscataway, NJ, USA). The Nanosep Centrifugal-3 k Ultrafiltration Device was obtained from Pall Corporation (Ann Arbor, MI, USA). Maxi plates were obtained from SPL Life Sciences (Gyeonggi-do, Korea). Anti-DYKDDDDK-HRP conjugate antibody was obtained from (Biolegend, CA, USA) and 3,3′,5,5′-Tetramethylbenzidine (TMB) was obtained from Sigma (St. Louis, MO, USA). Purified MMP9 protein was obtained from Sino (Beijing, China). Purified catalytic domain of MMP9 was obtained from Abcam (Cambridge, United Kingdom). Other chemicals and reagents, unless otherwise indicated, were from Sigma (Seoul, Korea).
+ Open protocol
+ Expand
6

Cloning and Engineering Neuroligin Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nlgn constructs were cloned from mouse cDNA into the pDisplay vector in frame with the N-terminal IgK signal sequence and HA tag but out of frame of the PDGFR tail. NL-1 splice variants were produced via inverse PCR of A1,A2,B “all in” NL-1 to delete each splice site either alone or in combination. Nrx-1β was cloned similarly but the HA tag was replaced with a V5 via PCR. NL-1GPI was produced by amplification of the NL-1 cDNA corresponding to amino acids 46 to 690 with homologous primer tails homologous to the NCAM GPI-anchoring plasmid reported previously (8 (link)). Barnase and Barstar from Bacillus amyloliquifasciencs cDNAs were codon-optimized and synthesized with homologous ends to existing NL-1 or Nrx-3β plasmids and ligated with In-fusion enzyme (Takara Bio). A graphical summary of the design of major fusion constructs used can be found in SI Appendix, Fig. S2. All plasmids were fully commercially sequenced prior to experimental application.
+ Open protocol
+ Expand
7

Generating Strep-tagged mouse and human GPX4 plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
p442-Strep-tagged mouse GPX4WT and GPX4U46C plasmids containing the endogenous selenocysteine insertion sequence of GPX4 were used as expressing vector.21 (link) 141-Strep tagged-human GPX4WT and GPX4U46C expression plasmids were generated by subcloning from the sequence of p442-human GPX4-blast vector (short form of GPX4, GenBank: NM_001367832.1)7 (link) using PCR and followed by the seamless cloning with In-Fusion enzyme (Takara, Cat#638948) and EcoRI digested plasmids. Human GPX4 U46C (tga>tgc) mutant was generated by PCR with the following primers (forward: 5′-aacgtggcctcccagtgCggcaagaccgaagta-3′, and reverse: 5′-tacttcggtcttgccGcactgggaggccacgtt-3′).36 (link) The final sequence of the insert into the plasmid was confirmed by Sanger sequencing as follows; the amino acid sequence is described in Figure S1.
+ Open protocol
+ Expand
8

Lentiviral CRISPR-Cas9 Targeting Bcl-xL

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained a pRRL plasmid expressing a Cas9-T2A cassette from Daniel Stetson (University of Washington), described in Gray et al., 2016 [55 (link)]. Guide RNAs specific to each gene were inserted into pRRL using the In-Fusion cloning system (Takara Bio). Briefly, sense and anti-sense sgRNAs were annealed to form a gRNA. These gRNAs were cloned into the pRRL plasmid using the In-Fusion enzyme (Takara Bio). Cloned plasmids were then transformed into Stellar Competent E. Coli cells and antibiotic selected. Single colonies were grown up and plasmids were isolated using the Qiagen Mini-Prep Kit. Lentivirus targeting Bcl-xL or the non-targeting control was generated by co-transfection of 293T cells.
+ Open protocol
+ Expand
9

Functional Characterization of Potassium Transporters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primer Premier 5 was used to design primers (Additional file 11), and the synthesized cDNA from RNA of YT55 after 12 h of low-potassium stress treatment was used as a template to amplify SsHAK1 and SsHAK21. The amplified products were recovered from the gel and ligated to the expression vector pYES2.0 with In-Fusion enzyme (TaKaRa Biotechnology Co., Ltd., Dalian, China). The ligation products were transformed into E. coli competent DH5α cells. Positive monoclonal clones were selected and verified by sequencing, and then the plasmids were extracted for subsequent yeast transformation. Competent cells of yeast mutant strain R5421 were prepared with the S.c. EasyComp™ Transformation Kit (Invitrogen, Carlsbad, CA, USA) and transformed. Yeast strains with the empty vector and target genes were isolated and then used for gradient dilution and inoculated in SC/−ura medium with 100 mM, 5 mM and 0 mM KCl. The results were observed after 3–5 days of culture at 30 °C.
+ Open protocol
+ Expand
10

Functional Characterization of SsCBL01 in Yeast

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cloning of the full-length cDNA of SsCBL01 was carried out using YT55 cDNA. The PCR product was recovered and was ligated using In-Fusion enzyme (TaKaRa Biotechnology Co., Ltd., Dalian, China) to the yeast expression vector pYES3/CT. The PCR products were converted into E. coli-competent JM109 cells and monoclonal colonies were selected for PCR. The plasmid confirmed to be carrying SsCBL01 and the empty vector pYES3/CT were transformed into the yeast mutant strain R5421 competent cells to screen positive colonies in SD/−trp medium. Positive yeasts were incubated in a liquid medium overnight to saturation before adjusting the yeast concentration to OD600 = 0.8. Yeast strains (R5421) with the empty vector pYES3/CT and SsCBL01 were employed for gradient dilution and inoculated in SD/−trp media containing 0 mM, 10 mM, or 100 mM KCl for 3–5 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!